Value-Based Care and Kidney Disease: Emergence and Future Opportunities

被引:9
作者
Tummalapalli, Sri Lekha [1 ,2 ,5 ]
Mendu, Mallika L. [3 ,4 ]
机构
[1] Weill Cornell Med, Dept Populat Hlth Sci, Div Healthcare Delivery Sci & Innovat, New York, NY USA
[2] Rogosin Inst, New York, NY USA
[3] Brigham & Womens Hosp, Harvard Med Sch, Div Renal Med, Boston, MA USA
[4] Mass Gen Brigham, Ctr Populat Hlth, Boston, MA USA
[5] Dept Populat Hlth Sci, Div Healthcare Delivery Sci & Innovat, 402 East 67th St, New York, NY 10065 USA
关键词
Value-based care; Alternative payment models; Chronic kidney disease; End-stage renal disease; Population health; future health policy changes; PAY-FOR-PERFORMANCE; HOSPITAL READMISSIONS; REDUCTION PROGRAM; ESRD; FACILITY; HEALTH; PENALTIES; IMPACT; RISK; ASSOCIATION;
D O I
10.1053/j.ackd.2021.10.001
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The United States health care system has increasingly embraced value-based programs that reward improved outcomes and lower costs. Health care value, defined as quality per unit cost, was a major goal of the 2010 Patient Protection and Affordable Care Act amid high and rising US health care expenditures. Many early value-based programs were specifically designed for patients with end-stage renal disease (ESRD) and targeted toward dialysis facilities, including the ESRD Prospective Payment System, ESRD Quality Incentive Program, and ESRD Seamless Care Organizations. While a great deal of attention has been paid to these ESRD-focused programs, other value-based programs targeted toward hospitals and health systems may also affect the quality and costs of care for a broader population of patients with kidney disease. Value-based care for kidney disease is increasingly relevant in light of the Advancing American Kidney Health initiative, which introduces new value-based payment models: the mandatory ESRD Treatment Choices Model in 2021 and voluntary Kidney Care Choices Model in 2022. In this review article, we summarize the emergence and impact of value-based programs on the quality and costs of kidney care, with a focus on federal programs. Key opportunities in value-based kidney care include shifting the focus toward chronic kidney disease, enhancing population health management capabilities, improving quality measurement, and leveraging programs to advance health equity.Q 2021 by the National Kidney Foundation, Inc. All rights reserved.
引用
收藏
页码:30 / 39
页数:10
相关论文
共 50 条
  • [31] Chronic Kidney Disease: Exploring Value-Based Healthcare as a Potential Viable Solution
    Busink, Ellen
    Canaud, Bernard
    Schroeder-Baeck, Peter
    Paulus, Aggie T. G.
    Evers, Silvia M. A. A.
    Apel, Christian
    Bowry, Sudhir K.
    Stopper, Andrea
    [J]. BLOOD PURIFICATION, 2019, 47 (1-3) : 156 - 165
  • [32] Accounting for accountable care: Value-based population health management
    Hogle, Linda F.
    [J]. SOCIAL STUDIES OF SCIENCE, 2019, 49 (04) : 556 - 582
  • [33] Defining Value-Based Care in Cardiac and Vascular Anesthesiology: The Past, Present, and Future of Perioperative Cardiovascular Care
    Kolarczyk, Lavinia M.
    Arora, Harendra
    Manning, Michael W.
    Zvara, David A.
    Isaak, Robert S.
    [J]. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2018, 32 (01) : 512 - 521
  • [34] Nursing Care Value-Based Financial Models
    Welton, John M.
    Harper, Ellen M.
    [J]. NURSING ECONOMICS, 2015, 33 (01): : 14 - +
  • [35] Towards Value-Based Health Care in Medicare
    Scott, Anthony
    [J]. AUSTRALIAN ECONOMIC REVIEW, 2015, 48 (03) : 305 - 313
  • [36] Value-based Surgical Care: Evidence for the Enigma
    Tatarian, Talar
    Aggarwal, Rajesh
    [J]. ANNALS OF SURGERY, 2018, 268 (01) : 28 - 29
  • [37] Cardiac CT in the context of value-based care
    Nicol, Ed
    Shaw, Leslee J.
    [J]. JOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY, 2025, 19 (01) : 126 - 131
  • [38] The role of biosimilars in value-based oncology care
    Patel, Kashyap B.
    Arantes, Luiz H., Jr.
    Tang, Wing Yu
    Fung, Selwyn
    [J]. CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 4591 - 4602
  • [39] Integrating Ambulatory Care Pharmacists Into Value-Based Primary Care: A Scalable Solution to Chronic Disease
    Blood, Alexander J.
    Saag, Harry
    Chesler, Adam
    Ameripour, Dalia
    Gutierrez, Max
    Nguyen, Van
    Richardson, Cassandra
    Fields, Clive
    Clair, Jen
    Yao, Aaron
    Moodley, Sashi
    [J]. JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2025, 16
  • [40] Value-Based Insurance Design and Medication Adherence: Opportunities and Challenges
    Look, Kevin A.
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2015, 21 (01) : E78 - E90